Trileptal Drug Classification
Trileptal (oxcarbazepine) is an antiepileptic drug (AED), also known as an antiseizure medication. 1, 2
Primary Drug Class
Oxcarbazepine belongs to the antiepileptic drug (AED) class, specifically developed as a structural analog of carbamazepine to provide similar efficacy with improved tolerability. 1, 2
The American Academy of Neurology and American Epilepsy Society classify oxcarbazepine among the "new antiepileptic drugs" approved by the FDA in the last several decades for seizure management. 1
Mechanism of Action Classification
Oxcarbazepine functions as a voltage-gated sodium channel (VGSC) modulator, which is its primary mechanism of antiseizure activity. 3, 2
The drug produces blockade of voltage-sensitive sodium channels, resulting in stabilization of hyperexcited neural membranes and inhibition of repetitive neuronal firing. 2
Additional mechanisms include increased potassium conductance and modulation of high-voltage activated calcium channels, which may contribute to anticonvulsant effects. 2
Pharmacological Characteristics
Oxcarbazepine acts primarily as a prodrug, being rapidly reduced by cytosolic hepatic enzymes to its pharmacologically active 10-monohydroxy metabolite (MHD), which is responsible for most antiepileptic activity. 2, 4
The drug undergoes reductive metabolism rather than oxidative metabolism via the cytochrome P450 system, distinguishing it from carbamazepine and resulting in fewer drug interactions. 4, 5
Oxcarbazepine can inhibit CYP2C19 and induce CYP3A4/5, which affects plasma concentrations of certain other medications. 2
Clinical Classification Context
While technically classified as an antiseizure drug rather than an "antiepileptic" drug (since it treats seizures but not the underlying epilepsy), the term AED remains widely used among clinicians. 1
Oxcarbazepine is also sometimes used off-label for psychiatric conditions including bipolar disorder and mood stabilization, though its primary FDA-approved indication remains epilepsy. 6, 7